September 19, 2014 6:09 AM ET

Pharmaceuticals

Company Overview of EUSA Pharma (USA), Inc.

Company Overview

EUSA Pharma (USA), Inc. develops, produces, and commercializes a portfolio of specialty pharmaceutical products for the treatment of cancer. It markets QUADRAMET (samarium Sm-153 lexidronam injection), PROSTASCINT (capromab pendetide), and SOLTAMOX (tamoxifen citrate) to the United States oncology market. QUADRAMET is approved for the treatment of pain in patients whose cancer has spread to the bone, PROSTASCINT is a prostate-specific membrane antigen (PSMA)-targeting monoclonal antibody-based agent to image the extent and spread of prostate cancer, and SOLTAMOX is the liquid hormonal therapy approved in the United States for the treatment of breast cancer in adjuvant and metastatic settings...

1717 Langhorne-Newtown Road

One Summit Square

Suite 201

Langhorne, PA 19047

United States

Founded in 1980

76 Employees

Phone:

215-867-4900

Fax:

215-579-0384

Key Executives for EUSA Pharma (USA), Inc.

Vice President of Research
Head of Investor Relations
Vice President of Finance
Age: 53
Senior Director of Sales
Vice President of Medical Affairs
Age: 63
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Legacy Pharmaceuticals Puerto Rico, LLC United States
BioRexis Pharmaceuticals Corporation United States
Vesta Pharmaceuticals, Inc. United States
AnazaoHealth United States
P. J. Noyes Company, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EUSA Pharma (USA), Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.